GGrantIndex
Sort

130,381 grants matching hiv

Core C

$786,278
Jinwoo Ahn · University Of Pittsburgh At Pittsburgh · P50 · FY2010 · GM

Longitudinal studies of HIV-1 Nef in Pulmonary Hypertension

$786,262
Sonia Castro Flores · University Of Colorado Denver · R01 · FY2007 · HL

Intersection of Material-Need Insecurities and HIV and Cardiovascular Health

$786,192
Sheri Dawn Weiser · University Of California, San Francisco · R01 · FY2022 · HL

A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENT

$786,175
University Of Wisconsin Madison · R01 · FY2001 · AI

Next-Generation Phylodynamics-targeted Partner Service Models for Combined HIV Prevention

$786,169
John Schneider · University Of Chicago · R01 · FY2022 · AI

Relationship of fungal translocation, inflammation, and pulmonary function in HIV

$786,162
Alison Morris · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · HL

Relationship of fungal translocation, inflammation, and pulmonary function in HIV

$786,162
Alison Morris · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL

Preclinical modeling to study Tuberculous Meningitis

$786,130
Sanjay Jain · Johns Hopkins University · R01 · FY2023 · AI

HIV Persistence and Renewal in the Gastrointestinal, Genitourinary and Adipose Tissues

$786,123
David Mitchell Smith · University Of California, San Diego · R01 · FY2022 · DK

Development of a Self Inactivating, Highly Effective TB Vaccine

$786,054
Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI

SOUTH AFRICAN MEN HEALTH PROMOTION PROJECT

$786,049
John Barton Jemmott · University Of Pennsylvania · R01 · FY2008 · HD

Identification of the Initial Targets of Transmission

$786,043
Thomas Hope · Northwestern University At Chicago · R37 · FY2020 · AI

Identification of the Initial Targets of Transmission

$786,043
Thomas Hope · Northwestern University At Chicago · R37 · FY2020 · AI

CBA (HIV) PREVENTION SERVICES FOR RACIAL/ETHNIC MINORITY POPULATIONS

$786,005
Debra Olesen · John Snow, Inc. · U65 · FY2009 · PS

Pharmacokinetics and Biodistribution of Antiretrovirals and HIV-1 in Macaques

$785,977
Patrick Franklin Kiser · Albert Einstein College Of Medicine, Inc · U19 · FY2016 · AI

WOMEN AND INFANTS TRANSMISSION STUDY

$785,925
University Of Puerto Rico Med Sciences · U01 · FY2001 · AI

Strengthening the HIV prevention continuum using pharmacies

$785,901
Natalie D. Crawford · Emory University · R01 · FY2023 · MH

Characterizing Sleep, ART Adherence and Viral Suppression Among Black Sexual Minority Men

$785,876
Dustin T Duncan · Columbia University Health Sciences · R01 · FY2022 · HL

Identification of small molecules for neurological complications of HIV and substance abuse comorbidity

$785,874
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2019 · DA

Adjuvants for Skin Immunization: Discovery and Mechanisms

$785,860
Ioanna Skountzou · Emory University · R01 · FY2016 · AI

HIV Release and Restriction

$785,807
David Bulkley · University Of Utah · P50 · FY2021 · AI

Defining HIV reservoirs that rebound following suspension of ART

$785,807
Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2020 · AI

St. Jude-Memphis Adolescent Trials Unit

$785,800
Patricia Michele Flynn · St. Jude Children'S Research Hospital · U01 · FY2007 · HD

HIGH RISK DRUG USE &HIV--LEARNING FROM THE NYC EPIDEMIC

$785,799
National Development &Res Institutes · P30 · FY2001 · DA

Improving the Organizational Social Context to Address Structural Racism and Discrimination: A Randomized Controlled Trial to Reduce Racial Disparities in Viral Suppression and Retention in HIV Care

$785,794
Florence M Momplaisir · University Of Pennsylvania · R01 · FY2023 · NR